ArticleClinical, cosmetic and investigational dermatology2025
The Hidden Epidemic of Topical Steroid Use: Prevalence and Impact Among Jordan's General Population.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Regional perspectives on substance use, substance use-related problems and policy: The case of Jordan.Addiction (Abingdon, England) · 2026Review
- From Cosmetic Abuse to Clinical Mismanagement: A National Simulated Patient Study Assessing Community Pharmacists' Stewardship of Topical Corticosteroids in Jordan.Pharmacy (Basel, Switzerland) · 2026Article
- The Prevalence, Knowledge, and Awareness Level of Atopic Dermatitis Among a Sample of Adult Jordanian Population.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Topical corticosteroids (TCS) are widely prescribed for inflammatory skin conditions, but unsupervised use carries significant health risks. In Jordan, over-the-counter availability raises concerns about misuse. Limited research exists on population-level patterns and knowledge. This study aimed to evaluate TCS use patterns, indications, and awareness in the general population, and to identify demographic factors associated with misuse. Methods: A cross-sectional online survey was distributed via social media platforms. The questionnaire assessed demographics, corticosteroid use patterns, application sites, prescription sources, and awareness of products and side effects. Data were analyzed using Jamovi (version 2.3.28). Descriptive statistics were generated, and chi-square tests and multiple linear regression were used to identify associations with cream recognition and adverse effect reporting. Results: A total of 714 respondents participated; 46.8% reported storing corticosteroid creams at home. The most common application sites were the hands (36.6%) and face (31.2%). Daily use was most frequent (53.1%). Creams were mainly obtained from pharmacists (22.8%) or informal sources (12.6%). Only 63.2% reported reading the leaflet, and 61.3% were aware of potential side effects. Hydrocortisone 1% was the most recognized cream (45.1%), while 29.5% could not identify any corticosteroid cream. The leading indications were eczema (32.6%) and itchiness (17%). Adverse effects were reported by 39.9%, most commonly redness, increased hair growth, and skin thinning. Chi-square analyses showed that adverse effect reporting was associated with longer duration and higher frequency of use (p < 0.05), while regression analysis demonstrated that cream recognition was lower among males and higher among employed or retired individuals compared with housewives (p < 0.05). Conclusion: Topical corticosteroid use is widespread in Jordan, often obtained without prescription and with limited awareness of potency, indications, and risks. Targeted public education and stricter regulation of dispensing are needed to reduce misuse and ensure safer use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.